Back to search

University of Crete (UOC)

The role of corticotropin releasing factor in the pathophysiology of schizophrenia

Abstract

dc:description

Schizophrenia (SZ) is a chronic, severe mental disorder, which affects 1% of the global population. Its main symptoms are categorized in positive, negative and cognitive deficits and arise after late adolescence/early adulthood. The main brain regions affected are the hippocampus (HPC) and the prefrontal cortex (PFC). Its biological basis still remains unknown, with several hypotheses trying to shed light on the underlying mechanisms. The leading hypothesis for the etiopathology of SZ is the neurodevelopmental hypothesis, which supports that SZ may originate from abnormalities that occur during the early stages of fetal brain development. Additionally, there are several lines of evidence supporting a crucial role of stress on SZ, while an important but rarely studied fact is the sexual dimorphism observed in the emergence, symptomatology and response to treatment. The multifactorial character of SZ has become a barrier for the identification of its biological basis and has magnified the need for developing more complex models for the study of the disorder. A very well-characterized animal model of SZ, based on the neurodevelopmental hypothesis, in rats, is the gestational MAM model. It is generated by prenatal exposure to the mitotoxin MAM, during Gestational day (GD) 17. Our study aimed to develop and validate the MAM model in mice, in both sexes, and investigate the role of corticotropin releasing factor (CRF) system, the neuroendocrine modulator of stress response, in the symptoms of the model. We further investigated the effects of acute stress in the cognitive function of control animals, in both sexes. Because of its good validity, we believe that developing the MAM model in mice, would provide us with a strong tool to create more complex models for the study of SZ, given the increased number of genetic mouse models. In addition, we believe that studying both sexes would further elucidate the complexity of SZ, as the majority of the studies have been conducted in male subjects.We showed that the MAM model in mice is better reproduced by exposure to the mitotoxin on GD16. The validation experiments revealed histological adaptations in both PFC and HPC, and indications of positive symptoms in both male and female mice, such as enhanced locomotor activity in response to MK-801 administration in female mice and reduced pre-pulse inhibition in male mice. With regards to cognitive deficits, HPC function was found impaired in both sexes, as shown by reduced contextual fear memory and decreased long-term potentiation (LTP). However, this was not the case for PFC-dependent cognitive function or the Parvalbumin protein expression. Only male mice exposed to MAM exhibited impaired PFC function, as indicated by reduced performance in the delayed alternation task in the T-maze and reduced LTP. Furthermore, male, but not female, MAM mice exhibited reduced Parvalbumin expression in HPC and PFC, which is a marker of SZ phenotype in humans.We extended the sex comparison of MAM-exposed mice in the basal anxiety levels and CRF1 receptor levels on PFC, which was the region showing sexual dimorphism. We revealed heightened levels of trait anxiety in MAM-exposed female mice but decreased levels in males, which were only observed during adulthood. The quantification of CRF1 protein levels from PFC samples revealed a significant decrease only in male MAM-exposed mice. These results intrigued us to hypothesize that CRF system could have a strong influence on the sex-biased PFC-dysfunction, through CRF1 activation, as our results supported normal PFC function in female MAM-exposed mice. We therefore, systemically blocked CRF1 in female MAM-16 mice, using antalarmin, which is a CRF1 specific antagonist. Our aim was to test whether CRF1 inactivation could induce PFC-dysfunction. We observed a disruption of LTP in the PFC of female MAM-exposed mice, in contrast to the facilitation we recorded in saline-exposed animals treated with antalarmin. Finally, we acutely stressed control animals, in order to study PFC-cognitive function after enhancing CRF system activation, mimicking the alterations that we observed in CRF system of male MAM-16 mice. We found increased vulnerability of females, in terms of anxiety levels, but no significant alterations were found in the PFC-dependent cognitive function.In conclusion, our study reveals that the MAM model of SZ can be successfully reproduced in mice, showing sex-dimorphic alterations observed also in the human condition, and supports a significant contribution of CRF system in the pathology of the disorder. We speculate that SZ could be a condition of sustained CRF over-expression and the altered levels of CRF1 in male MAM-expose mice could reflect a homeostatic mechanism developed to counterbalance this abnormal increase, with the cost of impaired PFC function. An alternative mechanism in female MAM-exposed mice, through the activation of different cellular signaling pathways could protect PFC, without affecting CRF1 availability.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chalkiadaki, Kleanthi
  • Χαλκιαδάκη, Κλεάνθη

Subjects

dc:subject × 6

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43720

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chalkiadaki, Kleanthi; Χαλκιαδάκη, Κλεάνθη. The role of corticotropin releasing factor in the pathophysiology of schizophrenia. University of Crete (UOC), 2018. http://hdl.handle.net/10442/hedi/43720